Researchers challenge new guidelines on aspirin in primary prevention
(Florida Atlantic University) New guidelines recommend aspirin use in primary prevention for people ages 40 to 70 years old who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at higher risks of cardiovascular events than those under 70. As a result, health care providers are understandably confused about whether or not to prescribe aspirin for primary prevention of heart attacks or strokes, and if so, to whom. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 17, 2020 Category: International Medicine & Public Health Source Type: news

Medications May Lower Risk Of ‘ Broken Heart ’ After Loss Of Loved One, Study Says
In this study, researchers at the University of Sydney looked at 85 spouses or parents grieving the loss of a family member. They found that those who received low doses of a beta blocker and aspirin for the first six weeks had lower spikes in blood pressure and heart rates and improvements in the tendency to form blood clots. They also had less symptoms of anxiety and depression. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 12, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall Source Type: news

A Daily Aspirin for Pregnancy?
Pregnant women who take a daily baby aspirin may reduce the risk for premature birth. (Source: NYT Health)
Source: NYT Health - February 11, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Aspirin Women and Girls Pregnancy and Childbirth Premature Babies Babies and Infants Source Type: news

Low-dose aspirin reduces preterm birth among first-time mothers
In a large trial, daily low-dose aspirin reduced the risk of preterm birth (before 37 weeks) by 11% and early preterm birth (before 34 weeks) by 25% among first-time mothers. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - February 10, 2020 Category: Consumer Health News Source Type: news

Dropping Aspirin Post PCI: Are We There Yet? Dropping Aspirin Post PCI: Are We There Yet?
Is P2Y12 inhibitor monotherapy post PCI ready to go mainstream? Michelle O'Donoghue considers the question of when to drop aspirin in the context of recent trials on antiplatelet therapy.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2020 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Ticagrelor Shows Benefit in Acute Stroke: THALES Topline Results Ticagrelor Shows Benefit in Acute Stroke: THALES Topline Results
Initial results from the phase 3 trial show a reduction in the primary endpoint of death or repeat stroke at 30 days with ticagrelor plus aspirin vs aspirin alone.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 27, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Could Colchicine Be the New Aspirin? Could Colchicine Be the New Aspirin?
Michel Zeitouni talks to Jean-Claude Tardif about the COLCOT series of clinical trials testing colchicine, an anti-inflammatory gout drug, for the prevention and treatment of cardiovascular disease.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2020 Category: Consumer Health News Tags: Cardiology Expert Interview Source Type: news

Low-Dose Aspirin Might Help Prevent Preterm Births
The trial, which was run in six lower-income countries, found that giving first-time mothers a daily low-dose aspirin reduced their risk of preterm birth by 11%. (Source: WebMD Health)
Source: WebMD Health - January 24, 2020 Category: Consumer Health News Source Type: news

Low-dose aspirin may reduce preterm birth risk among first-time mothers
The clinical trial involved more than 11,000 women in several low- and middle-income countries. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - January 24, 2020 Category: American Health Source Type: news

Low-Dose Aspirin Might Help Prevent Preterm Births
FRIDAY, Jan. 24, 2020 -- A daily baby aspirin helped first-time mothers lower their chances of delivering too soon in a new clinical trial, though it's not clear the practice should become routine everywhere. The trial, which was run in six... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 24, 2020 Category: General Medicine Source Type: news

Low-Dose Aspirin Cuts Preterm Delivery in Nulliparous Women
FRIDAY, Jan. 24, 2020 -- Among nulliparous women with singleton pregnancies from low-income and middle-income countries, the incidence of preterm delivery before 37 weeks is reduced for those receiving low-dose aspirin versus placebo, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 24, 2020 Category: Pharmaceuticals Source Type: news

Taking a quarter of aspirin pill a day could cut risk of premature birth, new research suggests
A study of almost 12,000 women found that taking 81 milligrams of aspirin a day - a quarter of a 300mg pill - from the sixth week of pregnancy to the 36th lowered the danger by 11 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - January 24, 2020 Category: Consumer Health News Source Type: news

Low-dose aspirin may reduce risk for pre-term birth in first-time mothers
First-time mothers may be able to reduce their risk for delivering pre-term by taking low-dose aspirin, a new study by researchers at the National Institute of Child Health and Human Development has found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 24, 2020 Category: Consumer Health News Source Type: news

Daily aspirin may reduce preterm birth risk among first-time mothers
Women who took low-dose aspirin were 11% less likely to give birth before the 37th week of pregnancy Related items fromOnMedica Poor asthma control in pregnancy linked to serious adverse outcomes New warning on epilepsy drugs in pregnancy Prenatal vitamins linked to lower ASD risk in siblings Caffeine in pregnancy linked to risk of child overweight Tool helps GPs predict risk of epilepsy seizures in pregnancy (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 24, 2020 Category: UK Health Source Type: news

‘You are our angels’
Her words hung in the hushed air.“Thank you for saving our boy,” the mother said, her voice choked by emotion.Devra Schwartz, and her husband, Jeff, recently had a chance to express their gratitude to eight of the 100 strangers whose blood donations provided a lifeline for their son, Judah, now 4. The Santa Monica youngster nearly died last year when his kidneys failed due to foodborne E. coli infection.Toxins in the E. coli bacteria ruptured Judah ’s red blood cells, leading to massive blood loss. His platelets — critical to clotting and preventing hemorrhage — plummeted to 13,000. A healthy ...
Source: UCLA Newsroom: Health Sciences - January 18, 2020 Category: Universities & Medical Training Source Type: news

Should everyone over 50 take a daily aspirin pill to cut their risk of certain cancers?
Aspirin is now only prescribed by NHS doctors to anyone who has had a heart attack or stroke, or to those at high risk because they have heart disease or had previous heart surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2020 Category: Consumer Health News Source Type: news

Aspirin appears to curb colorectal cancer recurrence and tumor growth
The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and inhibit recurrence of the disease. The trick now, researchers say, is to determine the right dosage of aspirin that can be used as a daily prophylactic without triggering dangerous side effects such as stomach and brain bleeds. (Source: World Pharma News)
Source: World Pharma News - January 8, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Daily dose of aspirin could lower bowel cancer risks, study suggests
Researchers at City of Hope Hospital in Duarte, California found that the higher daily dose of aspirin they gave mice each day, the more effectively they could stop colorectal tumor growth and recurrence. (Source: the Mail online | Health)
Source: the Mail online | Health - January 6, 2020 Category: Consumer Health News Source Type: news

Low-dose aspirin may help prevent colorectal cancer
A new study suggests over-the-counter aspirin may help prevent colorectal cancer. In experiments using mice, the authors found that a daily dose of aspirin was able to decrease tumor growth and kill off cancer cells. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 6, 2020 Category: Consumer Health News Source Type: news

Aspirin appears to curb colorectal cancer recurrence and tumor growth, study finds
(City of Hope) The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and inhibit recurrence of the disease. The trick now, researchers say, is to determine the right dosage of aspirin that can be used as a daily prophylactic without triggering dangerous side effects such as stomach and brain bleeds. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 6, 2020 Category: Cancer & Oncology Source Type: news

Watchdog rejects use of genetic disorders drug in the NHS
NICE will not approve volanesorsen on the NHS Related items fromOnMedica NICE recommends Herceptin for gastric cancer H. pylori eradication linked to reduced risk of gastric cancer Use of DPP-4 inhibitors associated with increased risk of IBD Aspirin could also treat cancer, research suggests Antivirals cut liver cancer risk after hepatitis C (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 6, 2020 Category: UK Health Source Type: news

Lay off the aspirin: Research says even "small doses" can cause brain hemorrhage
(Natural News) Taking aspirin, even in low doses, could lead to bleeding inside the skull, according to a report published in JAMA Neurology. Researchers from Taiwan and California investigated the link between low-dose aspirin and intracranial hemorrhage, a type of bleeding that occurs inside the skull. While any form of internal bleeding is considered a medical emergency, intracranial bleeding... (Source: NaturalNews.com)
Source: NaturalNews.com - January 1, 2020 Category: Consumer Health News Source Type: news

Association of Aspirin Use With Mortality Risk Among Older Adult Patients with Cancer
The use of aspirin 3 or more times a week was associated with a reduction in all-cause, cancer, gastrointestinal cancer, and colorectal cancer mortality in adults 65 and over, according to a study published in JAMA Network Open. (Source: CancerNetwork)
Source: CancerNetwork - December 27, 2019 Category: Cancer & Oncology Authors: Kevin Wright Source Type: news

FDA Approves New Drug For Migraine Sufferers
(CNN) — The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can’t take or don’t respond to migraine medications currently on the market. The drug will be sold under the name Ubrelvy by the pharmaceutical company Allergan. It is considered effective for migraine with or without aura, referring to the sensory or visual disturbances that occur among roughly a third of migraine sufferers. “Ubrelvy represents an important new option for the acute treatment of migraine in adults, as...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 24, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston FDA Migraines Source Type: news

Medical News Today: Aspirin: Friend or foe after breast cancer?
A new study focuses on DNA change to investigate why aspirin use is linked to different outcomes in different individuals after a breast cancer diagnosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 24, 2019 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Aspirin May No Longer Have Effect in Primary CVD Prevention
MONDAY, Dec. 23, 2019 -- Aspirin may not be effective for primary prevention of cardiovascular disease and cancer mortality, according to research published online Nov. 21 in Family Practice. Frank Moriarty, Ph.D., from the Royal College of Surgeons... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 23, 2019 Category: Pharmaceuticals Source Type: news

Aspirin for Reducing Your Risk of Heart Attack and Stroke: Know the Facts
Information on using aspirin daily, over-the-counter, with other medicines, as well as its side effects (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 16, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

DR ELLIE CANNON: Don't come to see me if you get flu... even if you're feeling as sick as a dog
Aspirin, paracetamol and ibuprofen can tackle some of the worst symptoms, bringing a temperature down and easing aches. Take them as soon as symptoms start, writes DR ELLIE CANNON. (Source: the Mail online | Health)
Source: the Mail online | Health - December 15, 2019 Category: Consumer Health News Source Type: news

Evidence Supports Use of High-Dose Aspirin for Migraine
FRIDAY, Dec. 13, 2019 -- Evidence supports the use of high-dose aspirin for treating acute migraine and low-dose aspirin for prevention of recurrent attacks, according to a review recently published in the American Journal of Medicine. Bianca... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2019 Category: Pharmaceuticals Source Type: news

A 63-Year-Old Man With Big Toe Pain: USMLE Question A 63-Year-Old Man With Big Toe Pain: USMLE Question
A 63-year-old man presents with an extremely painful right big toe. He is told that he should avoid aspirin. Why?Osmosis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 13, 2019 Category: Consumer Health News Tags: Med Students Interactive Quiz Source Type: news

A Runner Suddenly Developed Asthma. It Was Stranger Than It Seemed.
A 34-year-old woman goes to the emergency room for chest pain. Her reaction to painkillers provides a clue to what is really wrong. (Source: NYT Health)
Source: NYT Health - December 12, 2019 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Respiratory Diseases Asthma Allergies Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Aspirin Tough Mudder Source Type: news

Aspirin in Older Adults Linked to Fewer Deaths
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 12, 2019 Category: General Medicine Source Type: news

Black Patients May Not Benefit On Low-Dose Aspirin
Researchers analyzed 11 years of data from more than 65,000 people, ages 40-79, living in the American Southeast. More than two-thirds of the participants were black, and about two-thirds were at high risk for heart attack or stroke at the start of the study period. (Source: WebMD Health)
Source: WebMD Health - December 12, 2019 Category: Consumer Health News Source Type: news

Aspirin in Older Adults Linked to Fewer Deaths Aspirin in Older Adults Linked to Fewer Deaths
A new analysis has found that older adults (over 65 years) who regularly took aspirin had a significantly lower risk of both all-cause and cancer mortality.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 11, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Low-Dose Aspirin May Not Reduce Heart Risks for Black Americans, Study Finds
It’s fairly established medical science that people who have had heart attacks can take regular low doses of aspirin to significantly lower their risk of having another heart attack, or other heart problems including stroke. But it is still an open question whether or not people who haven’t had a heart event, but are at higher risk of one (because, for example) they have diabetes, high blood pressure, or elevated cholesterol levels), can also benefit from the over-the-counter painkiller and anti-inflammatory drug. A new study, published in the Journal of the American Heart Association, adds to that debate by ad...
Source: TIME: Health - December 11, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized aspirin Drugs Heart Disease Source Type: news

Fewer Blacks Use Aspirin Therapy for Primary Prevention of CVD
WEDNESDAY, Dec. 11, 2019 -- Low-dose aspirin is used less consistently by blacks than whites for the primary prevention of cardiovascular disease (CVD), and its impact on ischemic cardiac disease varies by race, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2019 Category: Pharmaceuticals Source Type: news

Low-dose aspirin may not reduce heart disease risk for everyone
In new research, low-dose aspirin -- or amounts ranging from 75 to 150 milligrams -- was not found to reduce the risk for heart attack among African-American adults. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 11, 2019 Category: Consumer Health News Source Type: news

Black Patients May Not Gain Heart Benefit From Low-Dose Aspirin
WEDNESDAY, Dec. 11, 2019 -- The daily use of low-dose aspirin against heart disease may have taken another knock. New research shows that the practice may not provide black Americans with any lowering of their heart attack risk. Researchers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 11, 2019 Category: General Medicine Source Type: news

Aspirin Key to Expanding Access to Effective Migraine Treatment? Aspirin Key to Expanding Access to Effective Migraine Treatment?
Aspirin is an effective option for acute treatment and prevention of recurrent attacks, particularly among patients who can't tolerate or afford newer, much more expensive medications.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 10, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Low-Dose Aspirin May Cut Dementia Risk in Women With Diabetes
TUESDAY, Dec. 10, 2019 -- Long-term use of low-dose aspirin may reduce the risk for dementia in women with type 2 diabetes, according to a study published online Dec. 4 in Diabetes Care. Chisa Matsumoto, M.D., Ph.D., from the Hyogo College of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 10, 2019 Category: Pharmaceuticals Source Type: news

Sometimes, Aspirin May Be Enough to Ease Migraines
TUESDAY, Dec. 10, 2019 -- A cheap, century-old drug in most Americans'medicine cabinets -- aspirin -- may come to the rescue for people suffering from migraines, a new study finds. While there are effective prescription medications, many migraine... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 10, 2019 Category: General Medicine Source Type: news

Sometimes, Aspirin May Be Enough to Ease Migraines
Title: Sometimes, Aspirin May Be Enough to Ease MigrainesCategory: Health NewsCreated: 12/10/2019 12:00:00 AMLast Editorial Review: 12/10/2019 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - December 10, 2019 Category: Neurology Source Type: news

Aspirin Plus a DOAC May Do More Harm Than Good in Some Aspirin Plus a DOAC May Do More Harm Than Good in Some
For some patients, combining aspirin and direct oral anticoagulant (DOAC) therapy may increase the rates of bleeding without protecting them from adverse thrombotic outcomes, a new study has found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 9, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Aspirin may no longer be effective as cardiovascular treatment
(Oxford University Press USA) A new paper in Family Practice, published by Oxford University Press, found that the widespread use of statins and cancer screening technology may have altered the benefits of aspirin use. Researchers concluded that aspirin no longer provides a net benefit as primary prevention for cardiovascular disease and cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 9, 2019 Category: International Medicine & Public Health Source Type: news

Aspirin's health benefits under scrutiny
(University of Georgia) Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 9, 2019 Category: International Medicine & Public Health Source Type: news

Low-Dose Aspirin Might Cut Cancer Risk, Especially for Overweight People
Title: Low-Dose Aspirin Might Cut Cancer Risk, Especially for Overweight PeopleCategory: Health NewsCreated: 12/4/2019 12:00:00 AMLast Editorial Review: 12/5/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 5, 2019 Category: Cancer & Oncology Source Type: news

Low-Dose Aspirin Might Cut Cancer Risk
Aspirin's protective effect appears particularly pronounced among people who are overweight -- those with a body mass index of 25 to 29.9, the results show. (Source: WebMD Health)
Source: WebMD Health - December 4, 2019 Category: Consumer Health News Source Type: news

Aspirin Use May Reduce Cancer, All-Cause Mortality in Seniors
WEDNESDAY, Dec. 4, 2019 -- Aspirin use three or more times per week is associated with reductions in all-cause, any cancer, gastrointestinal cancer, and colorectal cancer (CRC) mortality among older adults, according to a study published online Dec.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 4, 2019 Category: Pharmaceuticals Source Type: news

Taking aspirin three times a week may cut the risk of dying of  
People who take the anti-inflammatory, aspirin, regularly may have better odds of surviving colorectal, prostate and stomach cancers, suggests a new National Institutes of Health study. (Source: the Mail online | Health)
Source: the Mail online | Health - December 4, 2019 Category: Consumer Health News Source Type: news

Aspirin may reduce risk of death from certain cancers
Seniors 65 years of age and older with prostate, lung, colorectal or ovarian cancer who used aspirin three or more times per week were 15 percent less likely to die from their disease than those who didn't use it. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 4, 2019 Category: Consumer Health News Source Type: news